BRCA1 and hypoparathyroidism-retardation-dysmorphism syndrome: Lastly, the dataset from Tu Du Hospital lacked information regarding biomarkers, including BRCA1/2 and Homologous Recombination Deficiency (HRD) status, owing to site-specific clinical practices and treatment protocols.